The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors NCT03641287 Ovarian Cancer
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Malignant Ovari...
Ovarian Adenoca...
Ovarian Carcino...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Transit...
Ovarian Undiffe...
Primary Periton...
Primary Periton...
Primary Periton...
Exercise Counse...
Aerobic Exercis...
Physiological S...
Quality-of-Life...
Questionnaire A...
Best Practice
18 Years - University of Washington View Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer NCT00719303 Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Malignant Ovari...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Transit...
Primary Periton...
Stage IIA Fallo...
Stage IIA Ovari...
Stage IIB Fallo...
Stage IIB Ovari...
Stage IIC Fallo...
Stage IIC Ovari...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Undifferentiate...
Undifferentiate...
Behavioral Diet...
Compliance Moni...
Counseling
Educational Int...
Exercise Interv...
Laboratory Biom...
Quality-of-Life...
Questionnaire A...
18 Years - GOG Foundation View Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer NCT05415709 Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Serous ...
Primary Periton...
Primary Periton...
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIA1 Fal...
Stage IIIA1 Ova...
Stage IIIA2 Fal...
Stage IIIA2 Ova...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
Carboplatin
Cisplatin
Cytoreductive S...
Hyperthermic In...
Paclitaxel
Quality-of-Life...
Questionnaire A...
18 Years - Ohio State University Comprehensive Cancer Center View Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer NCT01074411 Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Ovarian Brenner...
Ovarian Clear C...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Serous ...
Ovarian Transit...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Undifferentiate...
Undifferentiate...
Bortezomib
Carboplatin
Laboratory Biom...
Pharmacological...
18 Years - National Cancer Institute (NCI) View Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer NCT00989651 Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Ovarian Brenner...
Ovarian Carcino...
Ovarian Carcino...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Transit...
Ovarian Undiffe...
Primary Periton...
Primary Periton...
Stage IIA Fallo...
Stage IIA Ovari...
Stage IIB Fallo...
Stage IIB Ovari...
Stage IIC Fallo...
Stage IIC Ovari...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Bevacizumab
Carboplatin
Cisplatin
Laboratory Biom...
Paclitaxel
Veliparib
18 Years - National Cancer Institute (NCI) View The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors NCT03641287 Ovarian Cancer
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Malignant Ovari...
Ovarian Adenoca...
Ovarian Carcino...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Transit...
Ovarian Undiffe...
Primary Periton...
Primary Periton...
Primary Periton...
Exercise Counse...
Aerobic Exercis...
Physiological S...
Quality-of-Life...
Questionnaire A...
Best Practice
18 Years - University of Washington View Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube Cancers NCT03924245 Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
High Grade Fall...
High Grade Ovar...
Ovarian Carcino...
Ovarian Clear C...
Ovarian Endomet...
Primary Periton...
Recurrent Endom...
Recurrent Ovari...
Recurrent Prima...
Entinostat
Olaparib
18 Years - Vanderbilt-Ingram Cancer Center View A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer NCT04092270 Endometrial Hig...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
FIGO Grade 1 En...
FIGO Grade 2 En...
Ovarian High Gr...
Ovarian Seromuc...
Ovarian Undiffe...
Platinum-Sensit...
Primary Periton...
Primary Periton...
Primary Periton...
Primary Periton...
Recurrent Fallo...
Recurrent Low G...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Prima...
Recurrent Prima...
Biospecimen Col...
Computed Tomogr...
Echocardiograph...
Magnetic Resona...
Multigated Acqu...
Pegylated Lipos...
Peposertib
18 Years - National Cancer Institute (NCI) View Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer NCT02345265 Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Ovarian Carcino...
Ovarian High Gr...
Ovarian High Gr...
Primary Periton...
Primary Periton...
Primary Periton...
Biopsy
Biospecimen Col...
Cediranib Malea...
Computed Tomogr...
Echocardiograph...
Magnetic Resona...
Multigated Acqu...
Olaparib
Questionnaire A...
18 Years - National Cancer Institute (NCI) View Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer NCT01074411 Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Ovarian Brenner...
Ovarian Clear C...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Serous ...
Ovarian Transit...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Undifferentiate...
Undifferentiate...
Bortezomib
Carboplatin
Laboratory Biom...
Pharmacological...
18 Years - National Cancer Institute (NCI) View Paclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer NCT02923739 Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Malignant Ovari...
Ovarian Adenoca...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Transit...
Ovarian Undiffe...
Primary Periton...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Bevacizumab
Emactuzumab
Laboratory Biom...
Paclitaxel
Pharmacological...
18 Years - M.D. Anderson Cancer Center View Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer NCT00108745 Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Ovarian Brenner...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Transit...
Ovarian Undiffe...
Primary Periton...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Clinical Observ...
Laboratory Biom...
Paclitaxel
Paclitaxel Poli...
Quality-of-Life...
- GOG Foundation View MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer NCT02068794 Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Malignant Ovari...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Transit...
Ovarian Undiffe...
Primary Periton...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Laboratory Biom...
Mesenchymal Ste...
Oncolytic Measl...
18 Years - Mayo Clinic View Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer NCT01167712 Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Ovarian Brenner...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Transit...
Ovarian Undiffe...
Primary Periton...
Stage IIA Fallo...
Stage IIA Ovari...
Stage IIB Fallo...
Stage IIB Ovari...
Stage IIC Fallo...
Stage IIC Ovari...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Bevacizumab
Carboplatin
Computed Tomogr...
Paclitaxel
Therapeutic Con...
18 Years - National Cancer Institute (NCI) View Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer NCT00888615 Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Ovarian Brenner...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Transit...
Ovarian Undiffe...
Primary Periton...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Elesclomol Sodi...
Paclitaxel
18 Years - GOG Foundation View First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer NCT01097746 Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
FIGO Stage III ...
FIGO Stage IIIA...
FIGO Stage IIIA...
FIGO Stage IIIA...
FIGO Stage IIIA...
FIGO Stage IIIA...
FIGO Stage IIIB...
FIGO Stage IIIC...
FIGO Stage IVA ...
FIGO Stage IVB ...
Malignant Ovari...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Transit...
Ovarian Undiffe...
Primary Periton...
Primary Periton...
Bevacizumab
Carboplatin
Paclitaxel
18 Years - M.D. Anderson Cancer Center View Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer NCT01504126 Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Undiffe...
Primary Periton...
Stage II Fallop...
Stage II Ovaria...
Stage IIA Fallo...
Stage IIA Ovari...
Stage IIB Fallo...
Stage IIB Ovari...
Stage IIC Fallo...
Stage IIC Ovari...
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Chemotherapy
Propranolol Hyd...
Quality-of-Life...
Therapeutic Con...
18 Years - M.D. Anderson Cancer Center View Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer NCT05276973 Fallopian Tube ...
Fallopian Tube ...
Ovarian Endomet...
Ovarian High Gr...
Primary Periton...
Primary Periton...
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Unresectable Fa...
Unresectable Fa...
Unresectable Ov...
Unresectable Ov...
Unresectable Pr...
Unresectable Pr...
Biopsy
Carboplatin
Ipatasertib
Paclitaxel
18 Years - National Cancer Institute (NCI) View Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer NCT00262847 Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Malignant Ovari...
Ovarian Brenner...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Serous ...
Ovarian Transit...
Primary Periton...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Undifferentiate...
Undifferentiate...
Bevacizumab
Carboplatin
Laboratory Biom...
Paclitaxel
Placebo
Quality-of-Life...
18 Years - National Cancer Institute (NCI) View Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer NCT00719303 Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Malignant Ovari...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Transit...
Primary Periton...
Stage IIA Fallo...
Stage IIA Ovari...
Stage IIB Fallo...
Stage IIB Ovari...
Stage IIC Fallo...
Stage IIC Ovari...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Undifferentiate...
Undifferentiate...
Behavioral Diet...
Compliance Moni...
Counseling
Educational Int...
Exercise Interv...
Laboratory Biom...
Quality-of-Life...
Questionnaire A...
18 Years - GOG Foundation View Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer NCT02502266 Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Transit...
Ovarian Undiffe...
Primary Periton...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Cediranib
Cediranib Malea...
Computed Tomogr...
Magnetic Resona...
Olaparib
Paclitaxel
Pegylated Lipos...
Questionnaire A...
Topotecan
Topotecan Hydro...
18 Years - National Cancer Institute (NCI) View Paclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer NCT02923739 Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Malignant Ovari...
Ovarian Adenoca...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Transit...
Ovarian Undiffe...
Primary Periton...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Bevacizumab
Emactuzumab
Laboratory Biom...
Paclitaxel
Pharmacological...
18 Years - M.D. Anderson Cancer Center View First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer NCT01097746 Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
FIGO Stage III ...
FIGO Stage IIIA...
FIGO Stage IIIA...
FIGO Stage IIIA...
FIGO Stage IIIA...
FIGO Stage IIIA...
FIGO Stage IIIB...
FIGO Stage IIIC...
FIGO Stage IVA ...
FIGO Stage IVB ...
Malignant Ovari...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Transit...
Ovarian Undiffe...
Primary Periton...
Primary Periton...
Bevacizumab
Carboplatin
Paclitaxel
18 Years - M.D. Anderson Cancer Center View Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer NCT00565851 Clear Cell Aden...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Mucinous Adenoc...
Ovarian Brenner...
Ovarian Clear C...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Transit...
Ovarian Undiffe...
Primary Periton...
Primary Periton...
Primary Periton...
Primary Periton...
Primary Periton...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Undifferentiate...
Bevacizumab
Carboplatin
Docetaxel
Gemcitabine Hyd...
Laboratory Biom...
Paclitaxel
Quality-of-Life...
18 Years - National Cancer Institute (NCI) View APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion NCT04919629 Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Ovarian Carcino...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Serous ...
Primary Periton...
Primary Periton...
Primary Periton...
Primary Periton...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Bevacizumab
Biopsy
Biospecimen Col...
Pegcetacoplan
Pembrolizumab
Questionnaire A...
18 Years - Roswell Park Cancer Institute View YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving Chemotherapy NCT00899093 Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Malignant Ovari...
Malignant Ovari...
Malignant Ovari...
Malignant Ovari...
Malignant Ovari...
Malignant Ovari...
Malignant Ovari...
Malignant Ovari...
Ovarian Adenoca...
Primary Periton...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Undifferentiate...
Undifferentiate...
Cytology Specim...
Laboratory Biom...
18 Years - GOG Foundation View MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer NCT02364713 Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Ovarian Carcino...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Transit...
Ovarian Undiffe...
Platinum-Resist...
Platinum-Resist...
Platinum-Resist...
Primary Periton...
Primary Periton...
Primary Periton...
Primary Periton...
Primary Periton...
Primary Periton...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Bevacizumab
Gemcitabine Hyd...
Laboratory Biom...
Oncolytic Measl...
Paclitaxel
Pegylated Lipos...
Quality-of-Life...
Topotecan Hydro...
18 Years - Mayo Clinic View Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer NCT01504126 Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Undiffe...
Primary Periton...
Stage II Fallop...
Stage II Ovaria...
Stage IIA Fallo...
Stage IIA Ovari...
Stage IIB Fallo...
Stage IIB Ovari...
Stage IIC Fallo...
Stage IIC Ovari...
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Chemotherapy
Propranolol Hyd...
Quality-of-Life...
Therapeutic Con...
18 Years - M.D. Anderson Cancer Center View Bevacizumab and Anetumab Ravtansine or Paclitaxel in Treating Patients With Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer NCT03587311 Fallopian Tube ...
Fallopian Tube ...
Ovarian Endomet...
Ovarian High Gr...
Platinum-Resist...
Platinum-Resist...
Platinum-Resist...
Primary Periton...
Anetumab Ravtan...
Bevacizumab
Paclitaxel
18 Years - National Cancer Institute (NCI) View First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer NCT01097746 Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
FIGO Stage III ...
FIGO Stage IIIA...
FIGO Stage IIIA...
FIGO Stage IIIA...
FIGO Stage IIIA...
FIGO Stage IIIA...
FIGO Stage IIIB...
FIGO Stage IIIC...
FIGO Stage IVA ...
FIGO Stage IVB ...
Malignant Ovari...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Transit...
Ovarian Undiffe...
Primary Periton...
Primary Periton...
Bevacizumab
Carboplatin
Paclitaxel
18 Years - M.D. Anderson Cancer Center View MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer NCT02364713 Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Ovarian Carcino...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Transit...
Ovarian Undiffe...
Platinum-Resist...
Platinum-Resist...
Platinum-Resist...
Primary Periton...
Primary Periton...
Primary Periton...
Primary Periton...
Primary Periton...
Primary Periton...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Bevacizumab
Gemcitabine Hyd...
Laboratory Biom...
Oncolytic Measl...
Paclitaxel
Pegylated Lipos...
Quality-of-Life...
Topotecan Hydro...
18 Years - Mayo Clinic View APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion NCT04919629 Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Ovarian Carcino...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Serous ...
Primary Periton...
Primary Periton...
Primary Periton...
Primary Periton...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Bevacizumab
Biopsy
Biospecimen Col...
Pegcetacoplan
Pembrolizumab
Questionnaire A...
18 Years - Roswell Park Cancer Institute View Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer NCT00888615 Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Ovarian Brenner...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Transit...
Ovarian Undiffe...
Primary Periton...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Elesclomol Sodi...
Paclitaxel
18 Years - GOG Foundation View Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers NCT02020707 Cervical Adenoc...
Cervical Adenos...
Cervical Adenos...
Cervical Carcin...
Cervical Squamo...
Clinical Stage ...
Endometrial Ade...
Endometrial Cle...
Endometrial End...
Endometrial Mix...
Endometrial Muc...
Endometrial Ser...
Endometrial Und...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Malignant Femal...
Malignant Ovari...
Malignant Ovari...
Malignant Ovari...
Malignant Ovari...
Malignant Perit...
Malignant Solid...
Ovarian Carcino...
Ovarian Clear C...
Ovarian Endomet...
Ovarian High Gr...
Ovarian Mucinou...
Ovarian Serous ...
Ovarian Transit...
Ovarian Undiffe...
Platinum-Resist...
Platinum-Resist...
Platinum-Resist...
Platinum-Sensit...
Primary Periton...
Primary Periton...
Primary Periton...
Primary Periton...
Primary Periton...
Unresectable Me...
Uterine Corpus ...
Bevacizumab
Laboratory Biom...
Nab-paclitaxel
Pharmacological...
18 Years - Mayo Clinic View